Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Issue 8 (3rd April 2015)

• Record Type: Journal Article
• Authors: Dodel, Richard; Belger, Mark; Reed, Catherine; Wimo, Anders; Jones, Roy W.; Happich, Michael; Argimon, Josep M.; Bruno, Giuseppe; Vellas, Bruno; Haro, Josep Maria
• Is Part Of: Alzheimer's & dementia. Volume 11:Issue 8(2015)
• Page Start: 933
• Page End: 945
• Publication Date: 2015-04-03
• Subjects: Alzheimer's disease -- Cost of illness -- Dementia -- Health care costs -- Factors; Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1016/j.jalz.2015.02.005
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: To identify the main factors associated with societal costs of Alzheimer's disease (AD) in community‐dwelling patients across three European countries. Methods: Baseline cost data from a prospective, observational study were used. Assessments included patients' cognition, activities of daily living (ADLs) and behavioral symptoms, and caregiver burden. Cost calculations (2010) from the societal perspective were based on patient/caregiver resource use. Generalized linear models estimated factors associated with costs. Results: Mean monthly costs per patient differed for France (€1881), Germany (€2349), and the UK (€2016), with informal care costs accounting for 50% to 61%. Independent factors associated with costs across all countries were ADL total score, patient living arrangements, caregiver working status, and caregiver burden (all P < .05). Additional factors were significant for the pooled cohort or individual countries. Conclusions: Several patient and caregiver factors, including factors associated with informal care, should be included when evaluating care options for patients with AD.